Holtzman Steven H has filed 3 insider transactions across 1 company since October 2024.
Most recent transaction: a grant/award of 9000 shares of Camp4 Therapeutics Corp ($CAMP) on June 25, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 25, 2025 | Camp4 Therapeutics Corp | $CAMP | Holtzman Steven H | Director | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 20,161,072 | 9999.99% | 0.04% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Holtzman Steven H | Director | C | Common Stock | 8917 | $0.00 | 108,946.0000 | 0 | 8.91% | 0.00% |
| Oct. 15, 2024 | Camp4 Therapeutics Corp | $CAMP | Holtzman Steven H | Director | C | Series A Prime Preferred Stock | 100014 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |